Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant.
Tymora Analytical Operations LLC, Purdue University and St. Jude Children's Research Hospital have been awarded a one-year, $300,000 Phase I STTR grant from the NIH. The groups will develop technology that could pinpoint the proteins inside cells affected by the disease so treatments can be more targeted.
"By showing which proteins are affected by the disease, this platform can highlight the differences between leukemia cells," said Anton Iliuk, chief technology officer of Tymora Analytical Operations. "Identifying these differences would enable doctors to prescribe individualized, more precise drug treatment regimens for each patient."
The new platform will be developed from the company's pIMAGO and PolyMAC technologies.
The principal investigator for the project is W. Andy Tao, associate professor of biochemistry in Purdue's College of Agriculture. He also is chief scientific officer at Tymora Analytical Operations. The co-investigator is Jun J. Yang of St. Jude Children's Research Hospital in Memphis.
Article adapted by Medical News Today from original press release. Source:
Please use one of the following formats to cite this article in your essay, paper or report:
Purdue University. "NIH grant could develop technology to help personalize leukemia treatments." Medical News Today. MediLexicon, Intl., 4 Oct. 2013. Web.
7 Dec. 2013. <http://www.medicalnewstoday.com/releases/266971>
Purdue University. (2013, October 4). "NIH grant could develop technology to help personalize leukemia treatments." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266971.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.